PACS Group (NYSE:PACS) CAO Sells $158,790.32 in Stock

PACS Group, Inc. (NYSE:PACS) CAO Michelle Lewis sold 3,172 shares of the company’s stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $50.06, for a total value of $158,790.32. Following the transaction, the chief accounting officer owned 340,338 shares in the company, valued at $17,037,320.28. This trade represents a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Michelle Renee Lewis also recently made the following trade(s):

• On Thursday, October 29th, Michelle Lewis sold 2,364 shares of PACS Group stock. The stock was sold at an average price of $50.04, for a total transaction of $118,294.56.
• On Wednesday, October 28th, Michelle Lewis sold 9,464 shares of PACS Group stock. The shares were sold at an average price of $50.12, for a total value of $474,335.68.

PACS Group Trading Down 1.0%

Shares of NYSE:PACS opened at $49.68 on Friday. The company has a market cap of $7.86 billion, a P/E ratio of 28.07, a P/E/G ratio of 1.42 and a beta of -0.14. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.91 and a current ratio of 0.91. The stock’s 50-day moving average is $44.64 and its 200-day moving average is $40.03. PACS Group, Inc. has a 52-week low of $10.31 and a 52-week high of $51.68.

PACS Group (NYSE:PACS) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $0.63 EPS for the quarter, topping analysts’ consensus estimates of $0.58 by $0.05. The company had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.46 billion. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. Equities research analysts predict that PACS Group, Inc. will post 2.13 earnings per share for the current year.

More PACS Group News

Here are the key news stories impacting PACS Group this week:

• Positive Sentiment: Quarterly results beat expectations and outlook rose. PACS reported Q3 EPS of $0.63 and revenue of $1.50 billion, topping estimates; adjusted EBITDA increased 33.6%. Management raised its 2026 revenue forecast to $5.95–$6.05 billion and adjusted EBITDA outlook to $685–$695 million. Q3 earnings coverage Raised 2026 outlook
• Positive Sentiment: Expansion and facility ramp-ups may support continued growth. Recent acquisitions in Florida and Texas, along with the Eduro deal, add about 8,400 beds. Company leaders cited occupancy near 90%, while newer facilities mature and move toward higher occupancy and patient acuity. Acquisitions and results Occupancy and acquisitions
• Positive Sentiment: Analysts raised targets and maintained bullish ratings. Truist lifted its target to $65 and kept Buy; Stephens raised its target to $64 with an Overweight rating. UBS also raised its target to $67 and maintained Buy. Truist target update Stephens forecast
• Negative Sentiment: Executives and a director disclosed stock sales. CEO Jason Murray and director Mark Hancock sold shares, as did the CAO. The transactions were made under pre-arranged Rule 10b5-1 plans, and the CEO and director retained substantial holdings, which may temper concerns. Director sale CEO sale

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in PACS. Cantor Fitzgerald Investment Advisors L.P. acquired a new stake in shares of PACS Group in the third quarter valued at about $1,920,000. Squarepoint Ops LLC increased its stake in shares of PACS Group by 94.7% in the second quarter. Squarepoint Ops LLC now owns 59,523 shares of the company’s stock valued at $2,538,000 after purchasing an additional 28,945 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in PACS Group in the 2nd quarter worth about $1,893,000. Engineers Gate Manager LP bought a new stake in shares of PACS Group in the 2nd quarter worth approximately $1,132,000. Finally, Smith Group Asset Management LLC acquired a new stake in shares of PACS Group during the first quarter worth $771,000.

Analyst Upgrades and Downgrades

PACS has been the topic of several recent analyst reports. Wall Street Zen cut shares of PACS Group from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 8th. Zacks Research downgraded PACS Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 9th. JPMorgan Chase & Co. lifted their target price on shares of PACS Group from $47.00 to $58.00 and gave the stock an “overweight” rating in a research report on Friday, September 4th. Stephens lifted their target price on PACS Group from $60.00 to $64.00 and gave the stock an “overweight” rating in a report on Thursday. Finally, Weiss Ratings raised shares of PACS Group from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday. Seven equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $61.33.

PACS Group Company Profile

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.